Real-World Treatment Study of Koselugo (Selumetinib)

Trial Identifier: D1346R00009
Sponsor: AstraZeneca
Start Date: June 2024
Primary Completion Date: September 2031
Study Completion Date: September 2031

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
South Korea Busan, South Korea
South Korea Chungcheongbuk-do, South Korea
South Korea Daejeon, South Korea
South Korea Gyeonggi-do, South Korea
South Korea Incheon, South Korea
South Korea Jeonnam, South Korea
South Korea Seoul, South Korea
South Korea Wonju-si, South Korea
South Korea Yangsan-si, South Korea